Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1985;78(Suppl 6):43–47.

Chemotherapy for non-seminomatous germ-cell tumours.

P M Wilkinson
PMCID: PMC1289490  PMID: 2582119

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansfield F. J., Korbitz B. C., Davis H. L., Jr, Ramirez G. Triple drug therapy in testicular tumors. Cancer. 1969 Sep;24(3):442–446. doi: 10.1002/1097-0142(196909)24:3<442::aid-cncr2820240304>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  2. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  3. Bosl G. J., Geller N., Cirrincione C., Hajdu S. I., Whitmore W., Jr, Nisselbaum J., Vugrin D., Golbey R. B. Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testis. Cancer. 1983 Jun 1;51(11):2121–2125. doi: 10.1002/1097-0142(19830601)51:11<2121::aid-cncr2820511128>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  4. Bosl G. J., Lange P. H., Fraley E. E., Nochomovitz L. E., Rosai J., Vogelzang N. J., Johnson K., Goldman A., Kennedy B. J. Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma. Possible importance of longer induction and shorter maintenance schedules. Am J Med. 1980 Apr;68(4):492–496. doi: 10.1016/0002-9343(80)90287-9. [DOI] [PubMed] [Google Scholar]
  5. Cheng E., Cvitkovic E., Wittes R. E., Golbey R. B. Germ cell tumors (II): VAB II in metastatic testicular cancer. Cancer. 1978 Nov;42(5):2162–2168. doi: 10.1002/1097-0142(197811)42:5<2162::aid-cncr2820420512>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  6. Einhorn L. H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977 Sep;87(3):293–298. doi: 10.7326/0003-4819-87-3-293. [DOI] [PubMed] [Google Scholar]
  7. Einhorn L. H. Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1981 Sep;41(9 Pt 1):3275–3280. [PubMed] [Google Scholar]
  8. Einhorn L. H., Williams S. D. Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer. 1980 Sep 15;46(6):1339–1344. doi: 10.1002/1097-0142(19800915)46:6<1339::aid-cncr2820460607>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  9. Fitzharris B. M., Kaye S. B., Saverymuttu S., Newlands E. S., Barrett A., Peckham M. J., McElwain T. J. VP16-213 as a single agent in advanced testicular tumors. Eur J Cancer. 1980 Sep;16(9):1193–1197. doi: 10.1016/0014-2964(80)90178-4. [DOI] [PubMed] [Google Scholar]
  10. Garnick M. B., Canellos G. P., Richie J. P., Stark J. J. Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1681–1686. [PubMed] [Google Scholar]
  11. Golbey R. B., Reynolds T. F., Vugrin D. Chemotherapy of metastatic germ cell tumors. Semin Oncol. 1979 Mar;6(1):82–86. [PubMed] [Google Scholar]
  12. Gormley P. E., Gangji D., Wood J. H., Poplack D. G. Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol. 1981;5(4):257–260. doi: 10.1007/BF00434394. [DOI] [PubMed] [Google Scholar]
  13. Hande K. R., Wedlund P. J., Noone R. M., Wilkinson G. R., Greco F. A., Wolff S. N. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res. 1984 Jan;44(1):379–382. [PubMed] [Google Scholar]
  14. Higby D. J., Wallace H. J., Jr, Albert D. J., Holland J. F. Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer. 1974 May;33(5):1219–1215. doi: 10.1002/1097-0142(197405)33:5<1219::aid-cncr2820330505>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  15. Kaye S. B., Begent R. H., Newlands E. S., Bagshawe K. D. Successful treatment of malignant testicular teratoma with brain metastases. Br Med J. 1979 Jan 27;1(6158):233–234. doi: 10.1136/bmj.1.6158.233-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kennedy B. J. Mithramycin therapy in advanced testicular neoplasms. Cancer. 1970 Oct;26(4):755–766. doi: 10.1002/1097-0142(197010)26:4<755::aid-cncr2820260403>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  17. LI M. C., WHITMORE W. F., Jr, GOLBEY R., GRABSTALD H. Effects of combined drug therapy on metastatic cancer of the testis. JAMA. 1960 Nov 5;174:1291–1299. doi: 10.1001/jama.1960.03030100059013. [DOI] [PubMed] [Google Scholar]
  18. Logothetis C. J., Samuels M. L., Trindade A. The management of brain metastases in germ cell tumors. Cancer. 1982 Jan 1;49(1):12–18. doi: 10.1002/1097-0142(19820101)49:1<12::aid-cncr2820490104>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  19. Mackenzie A. R. Chemotherapy of metastatic testis cancer. Results in 154 patients. Cancer. 1966 Oct;19(10):1369–1376. doi: 10.1002/1097-0142(196610)19:10<1369::aid-cncr2820191006>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  20. Newlands E. S., Bagshawe K. D. Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas. Lancet. 1977 Jul 9;2(8028):87–87. doi: 10.1016/s0140-6736(77)90088-5. [DOI] [PubMed] [Google Scholar]
  21. Newlands E. S., Begent R. H., Kaye S. B., Rustin G. J., Bagshawe K. D. Chemotherapy of advanced malignant teratomas. Br J Cancer. 1980 Sep;42(3):378–391. doi: 10.1038/bjc.1980.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Newlands E. S., Begent R. H., Rustin G. J., Parker D., Bagshawe K. D. Further advances in the management of malignant teratomas of the testis and other sites. Lancet. 1983 Apr 30;1(8331):948–951. doi: 10.1016/s0140-6736(83)92079-2. [DOI] [PubMed] [Google Scholar]
  23. Oliver R. T., Rohatiner A. A., Wrigley P. F., Malpas J. S. Chemotherapy of metastatic testicular tumours. Br J Urol. 1980 Feb;52(1):34–37. doi: 10.1111/j.1464-410x.1980.tb02916.x. [DOI] [PubMed] [Google Scholar]
  24. Peckham M. J., Barrett A., Husband J. E., Hendry W. F. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet. 1982 Sep 25;2(8300):678–680. doi: 10.1016/s0140-6736(82)90710-3. [DOI] [PubMed] [Google Scholar]
  25. Peckham M. J., Barrett A., Liew K. H., Horwich A., Robinson B., Dobbs H. J., McElwain T. J., Hendry W. F. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer. 1983 May;47(5):613–619. doi: 10.1038/bjc.1983.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
  27. Ramsey E. W., Bowman D. M., Weinerman B. The management of disseminated testicular cancer. Br J Urol. 1980 Feb;52(1):45–49. doi: 10.1111/j.1464-410x.1980.tb02918.x. [DOI] [PubMed] [Google Scholar]
  28. Read G., Johnson R. J., Wilkinson P. M., Eddleston B. Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) 1983 Nov 19;287(6404):1503–1505. doi: 10.1136/bmj.287.6404.1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Reynolds T. F., Vugrin D., Cvitkovic E., Cheng E., Braun D. W., Jr, O'Hehir M. A., Dukeman M. E., Whitmore W. F., Jr, Golbey R. B. VAB-3 combination chemotherapy of metastatic testicular cancer. Cancer. 1981 Aug 15;48(4):888–898. doi: 10.1002/1097-0142(19810815)48:4<888::aid-cncr2820480405>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  30. Samuels M. L., Holoye P. Y., Johnson D. E. Bleomycin combination chemotherapy in the management of testicular neoplasia. Cancer. 1975 Aug;36(2):318–326. doi: 10.1002/1097-0142(197508)36:2<318::aid-cncr2820360205>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  31. Samuels M. L., Howe C. D. Vinblastine in the management of testicular cancer. Cancer. 1970 May;25(5):1009–1017. doi: 10.1002/1097-0142(197005)25:5<1009::aid-cncr2820250504>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  32. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Corbett T. H., Griswold D. P., Jr cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459–1473. [PubMed] [Google Scholar]
  33. Stewart A. L., Wilkinson P. M. Rapid onset of acute myeloid leukaemia following radiotherapy and chemotherapy for metastatic seminoma of the testis. J Cancer Res Clin Oncol. 1981;100(1):109–111. doi: 10.1007/BF00405908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stoter G., Sleijfer D. T., Vendrik C. P., Schraffordt Koops H., Struyvenberg A., Van Oosterom A. T., Brouwers T. M., Pinedo H. M. Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma. Lancet. 1979 May 5;1(8123):941–945. doi: 10.1016/s0140-6736(79)91719-7. [DOI] [PubMed] [Google Scholar]
  35. Varini M., Cavalli F. Etoposide for therapy-resistant testicular tumors. Cancer Treat Rev. 1982 Jun;9 (Suppl):73–78. doi: 10.1016/s0305-7372(82)80082-0. [DOI] [PubMed] [Google Scholar]
  36. Vick N. A., Bigner D. D. Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function. J Neurol Sci. 1972 Sep;17(1):29–39. doi: 10.1016/0022-510x(72)90019-6. [DOI] [PubMed] [Google Scholar]
  37. Vugrin D., Cvitkovic E., Whitmore W. F., Jr, Cheng E., Golbey R. B. VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer. 1981 Mar 1;47(5):833–839. doi: 10.1002/1097-0142(19810301)47:5<833::aid-cncr2820470502>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  38. Vugrin D., Whitmore W. F., Jr, Golbey R. B. VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis. Cancer. 1983 Jan 15;51(2):211–215. doi: 10.1002/1097-0142(19830115)51:2<211::aid-cncr2820510207>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  39. Williams S. D., Einhorn L. H., Greco F. A., Oldham R., Fletcher R. VP-16-213 salvage therapy for refractory germinal neoplasms. Cancer. 1980 Nov 15;46(10):2154–2158. doi: 10.1002/1097-0142(19801115)46:10<2154::aid-cncr2820461008>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  40. Wittes R. E., Yagoda A., Silvay O., Magill G. B., Whitmore W., Krakoff I. H., Golbey R. B. Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin. Cancer. 1976 Feb;37(2):637–645. doi: 10.1002/1097-0142(197602)37:2<637::aid-cncr2820370205>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES